EFFECTS OF BRUCELLA ABORTUS AND LPS-BA ON LYMPHOKINE SECRETION
EFFECTS OF BRUCELLA ABORTUS AND LPS-BA ON LYMPHOKINE SECRETION
批准号:
3804895
负责人:
B GOLDING
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
B lymphocyte Brucella abortus HIV infections Wiskott Aldrich syndrome antibody receptor antigen antibody reaction cytokine receptors flow cytometry helper T lymphocyte human tissue humoral immunity immunoconjugates immunoregulation inborn immunodeficiency infant human (0-1 year) interferon inducers interferons interleukin 2 leukocyte activation /transformation lipopolysaccharides lymphokines receptor binding receptor expression secretion suppressor T lymphocyte tissue /cell culture viral vaccines
中文摘要
我们感兴趣的是BA作为人类发展的载体
疫苗,因为它的行为作为一个T-非依赖性1型抗原,
刺激人B细胞。 也就是说,它能够诱导人类B
细胞反应(i)在T细胞相对缺乏的情况下,(ii)新生儿
人B细胞和(iii)从患有
Wiskott-Aldrich综合征(X连锁免疫缺陷)。 这些属性
表明BA可能特别适合作为HIV-1携带者
诱导HIV-1感染者应答的衍生蛋白或肽
个体(CD 4 + T细胞功能受损)和新生儿,
HIV-1感染的母亲。 最近的证据表明,BA
部分依赖于T细胞因子,特别是IFNg。 在小鼠中,
诱导IFNg的能力可能与BA
以高滴度为特征的特定IgG亚类模式
IgG 2a。 这在病毒感染的背景下可能很重要,因为
IgG 2a对补体和Fc受体具有高亲和力。 主要
本课题的目的是研究BA对人T细胞的影响,
细胞,特别是在IFNg释放方面。 我很感兴趣的是,
确定BA是否可以触发CD 8 + T细胞亚群,因为这些
细胞保留在HIV-1感染的个体中。 刺激这些
后一种细胞可以诱导淋巴因子,从而绕过对淋巴细胞的需要。
CD 4+和CD 8+人T细胞能够应答BA,
分泌IFNg 人T细胞向BA释放IFNg可能是
在IL 2存在下协同增加。 这种协同作用是
这可能与BA能增加IL-2的表达有关
人T细胞表面的受体。我们用流动来证明
细胞仪
英文摘要
We are interested in BA as a carrier in the development of human
vaccines because it behaves as a T-independent type 1 antigen in
stimulating human B cells. That is, it is capable of inducing human B
cell responses (i) in the relative absence of T cells, (ii) in neonatal
human B cells and (iii) in B cells obtained from patients with the
Wiskott-Aldrich syndrome (X-linked immunodeficiency). These properties
suggest that BA may be particularly well suited as a carrier for HIV-1
derived proteins or peptides in eliciting responses from HIV-1 infected
individuals (with compromised CD4+ T cell function) and in neonates who
have HIV-1 infected mothers. Recent evidence suggests that BA is
partially dependent on T cell factors, in particular IFNg. In mice this
ability to induce IFNg is probably related to the observation that BA
elicits a certain IgG subclass pattern characterized by high titer
IgG2a. This may be important in the context of viral infections because
IgG2a has high affinity for complement and Fc receptors. The main
purpose of this project was to investigate the effect of BA on human T
cells, especially with respect to IFNg release. It was of interest to
determine whether BA could trigger the CD8+ T cell subset because these
cells are retained in HIV-1 infected individuals. Stimulation of these
latter cells may induce lymphokines and thus bypass the requirement for
CD4+ and CD8+ human T cells were capable of responding to BA and
secreting IFNg. The IFNg release by human T cells to BA could be
synergistically increased in the presence of IL2. This synergism was
probably due to the fact that BA could increase the expression of IL-2
receptor on the surface of human T cells. which we demonstrated by flow
cytometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES OF HUMAN T-HELPER CELL TYPE 1 AND TYPE 2 CYTOKINE RESPONSES
-
批准号:2569061
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
DEVELOPMENT OF T-CELL INDEPENDENT VACCINES FOR HIV-1 AND OTHER INFECTIOUS AGENTS
-
批准号:2569060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
DEVELOPMENT OF T-CELL INDEPENDENT VACCINES FOR HIV-1 AND OTHER INFECTIOUS AGENTS
-
批准号:3748295
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
IMMUNOCONJUGATES THAT WILL BE EFFECTIVE IN ELICITING ANTI-HIV RESPONSE
-
批准号:3804894
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:
IMMUNOCONJUGATES FOR BOOSTING IMMUNITY IN HIV INFECTED PERSONS
-
批准号:3811103
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:
CYTOKINE RELEASE AS A MECHANISM MEDIATING IGIV ADVERSE REACTIONS
-
批准号:6161374
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
CYTOKINE RELEASE AS A MECHANISM MEDIATING IGIV ADVERSE REACTIONS
-
批准号:2456643
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
STUDIES OF HUMAN T-HELPER CELL TYPE 1 AND TYPE 2 CYTOKINE RESPONSES
-
批准号:3770447
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
DEVELOPMENT OF T-INDEPENDENT VACCINES FOR HIV-1 INFECTION
-
批准号:3792632
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:
EFFECT OF BRUCELLA ABORTUS ON INTERFERON-GAMMA RELEASE
-
批准号:3811104
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:
DEVELOPMENT OF T-CELL INDEPENDENT VACCINES FOR HIV-1 AND OTHER INFECTIOUS AGENTS
-
批准号:3770446
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
STUDIES OF HUMAN T-HELPER CELL TYPE 1 AND TYPE 2 CYTOKINE RESPONSES
-
批准号:5200856
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
TH1-TYPE RESPONSES BY HUMAN T CELLS STIMULATED BY BRUCELLA ABORTUS
-
批准号:3792633
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:
DEVELOPMENT OF T-CELL INDEPENDENT VACCINES FOR HIV-1 AND OTHER INFECTIOUS AGENTS
-
批准号:5200855
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
STUDIES OF HUMAN T-HELPER CELL TYPE 1 AND TYPE 2 CYTOKINE RESPONSES
-
批准号:3748296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
CYTOKINE RELEASE AS A MECHANISM MEDIATING IGIV ADVERSE REACTIONS
-
批准号:6101316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:B GOLDING
-
依托单位:--
海外基金